MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 31 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,463,743 | +21.2% | 37,413 | +91.7% | 0.00% | +100.0% |
| Q2 2023 | $4,508,808 | +16.0% | 19,519 | +21.7% | 0.00% | 0.0% |
| Q1 2023 | $3,886,250 | -47.6% | 16,041 | -37.2% | 0.00% | -50.0% |
| Q4 2022 | $7,409,502 | +339.2% | 25,528 | -1.6% | 0.00% | +100.0% |
| Q3 2022 | $1,687,000 | -26.8% | 25,953 | -19.4% | 0.00% | 0.0% |
| Q2 2022 | $2,306,000 | -3.7% | 32,208 | +32.0% | 0.00% | 0.0% |
| Q1 2022 | $2,394,000 | +0.5% | 24,403 | -13.2% | 0.00% | 0.0% |
| Q4 2021 | $2,382,000 | +4.1% | 28,104 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $2,288,000 | -24.2% | 28,665 | -7.4% | 0.00% | 0.0% |
| Q2 2021 | $3,017,000 | -24.0% | 30,970 | -8.8% | 0.00% | 0.0% |
| Q1 2021 | $3,971,000 | -18.6% | 33,951 | -22.6% | 0.00% | 0.0% |
| Q4 2020 | $4,879,000 | +421.3% | 43,891 | +456.7% | 0.00% | – |
| Q3 2020 | $936,000 | -15.2% | 7,884 | -19.1% | 0.00% | – |
| Q2 2020 | $1,104,000 | +105.6% | 9,750 | +21.4% | 0.00% | – |
| Q1 2020 | $537,000 | -45.4% | 8,034 | -25.5% | 0.00% | – |
| Q4 2019 | $983,000 | +22.1% | 10,779 | +15.6% | 0.00% | – |
| Q3 2019 | $805,000 | +7.2% | 9,326 | +30.2% | 0.00% | – |
| Q2 2019 | $751,000 | -8.4% | 7,164 | +9.5% | 0.00% | – |
| Q1 2019 | $820,000 | +59.2% | 6,545 | +43.3% | 0.00% | – |
| Q4 2018 | $515,000 | -82.5% | 4,568 | -66.8% | 0.00% | -100.0% |
| Q3 2018 | $2,944,000 | +4.8% | 13,749 | +36.9% | 0.00% | 0.0% |
| Q2 2018 | $2,808,000 | +203.2% | 10,040 | +26.6% | 0.00% | – |
| Q1 2018 | $926,000 | +27.5% | 7,928 | +0.3% | 0.00% | – |
| Q4 2017 | $726,000 | +3721.1% | 7,901 | +1785.7% | 0.00% | – |
| Q3 2017 | $19,000 | +850.0% | 419 | +215.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 133 | +3.9% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 128 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 128 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |